Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy
September 21, 2024 at 14:40 PM EDT
Japan’s Nippon Shinyaku will acquire European rights for a Duchenne muscular dystrophy disease therapy developed by Capricor Therapeutics of San Diego. Nippon Shinyaku will pay $20 million upfront and up to $715 million in milestones, plus royalties.
